MyHep LVIR – Generic Harvoni

Description

MyHep LVIR is a fixed-dose combination medication manufactured by Mylan Pharmaceuticals, designed for the treatment of chronic Hepatitis C virus (HCV) infection. Each tablet combines Ledipasvir 90 mg and Sofosbuvir 400 mg, two potent direct-acting antiviral agents (DAAs) that work together to prevent the virus from multiplying and spreading in the body.

This combination directly targets the enzymes required by the hepatitis C virus to replicate — NS5A and NS5B — effectively reducing the viral load and helping achieve a sustained virologic response (SVR), which is considered a cure.

MyHep LVIR is typically used as a 12-week treatment without the need for interferon or ribavirin in most cases. It is particularly effective for genotype 1, the most common form of Hepatitis C, as well as genotypes 4, 5, and 6.

Key Features:

• Contains Ledipasvir 90 mg + Sofosbuvir 400 mg
• Effective for HCV genotypes 1, 4, 5, and 6
• Once-daily convenient oral tablet
• High cure rate with a well-tolerated side effect profile
• Manufactured by Mylan – a trusted global pharmaceutical brand

Recommended Use & Dosage:

• Dosage: One tablet orally, once daily, with or without food.
• Treatment Duration: Generally 12 weeks, but may vary depending on liver condition (e.g., presence of cirrhosis) and previous treatment history.
• Always take as prescribed by your healthcare provider.

Precautions:

• Not recommended for patients with severe renal or liver impairment without medical supervision.
• Use with caution in pregnant or breastfeeding women. Consult your physician.
• Inform your doctor about all current medications to avoid drug interactions.
• Do not stop the medication early, even if you feel better, unless advised by your doctor.

Storage Instructions:

• Store in a cool, dry place at a temperature below 30°C.
• Keep away from light, moisture, and out of reach of children.

FAQs – MyHep LVIR

Q1: What is MyHep LVIR used for?
A: MyHep LVIR is used to treat chronic Hepatitis C virus infection (mainly genotypes 1, 4, 5, and 6). It helps reduce the virus in the body and may lead to a complete cure after the full treatment course.

Q2: What is in MyHep LVIR?
A: Each tablet contains a combination of Ledipasvir (90 mg) and Sofosbuvir (400 mg), two direct-acting antivirals.

Q3: How effective is MyHep LVIR?
A: MyHep LVIR has shown cure rates of 95% or higher in patients with genotype 1 after 12 weeks of therapy.

Q4: How long do I need to take MyHep LVIR?
A: The standard treatment duration is 12 weeks. However, this may vary based on your liver condition and if you’ve had treatment before.

Q5: What are common side effects of MyHep LVIR?
A: Common side effects may include:

• Fatigue
• Headache
• Nausea
• Insomnia

Most side effects are mild and temporary. Contact your doctor if you experience severe side effects.

Q6: Can I take MyHep LVIR with food?
A: Yes. MyHep LVIR can be taken with or without food.

Q7: Can I drink alcohol while taking MyHep LVIR?
A: Alcohol is best avoided during treatment, as it can affect liver health and reduce the effectiveness of the medication.

Q8: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember. If it is close to your next dose, skip the missed one. Do not take two doses at once.

Q9: Is a prescription required to buy MyHep LVIR?
A: Yes, this is a prescription-only medication and should only be used under the supervision of a qualified healthcare provider.

Q10: Is MyHep LVIR safe during pregnancy?
A: Use during pregnancy is not advised unless absolutely necessary. Always consult your doctor if you are pregnant, planning to conceive, or breastfeeding.